Guidelines International Network: Principles for Disclosure of Interests and Management of Conflicts in Guidelines
The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Conflicts of interest (COIs) have been defined by the American Thoracic Society as "a divergence between an individual's private interests and his or her professional obligations such that an independent observer might reasonably question whether the individual's professional actions or decisions are motivated by personal gain, such as direct financial, academic advancement, clinical revenue streams, or community standing." In the context of guideline development, the concerns are not simply about identifying and disclosing direct financial or indirect COIs. Despite this recognition, the management of COIs in guidelines is often unsatisfactory. In response to requests from its international membership and informed by existing syntheses of the evidence and policies of international organizations, the Guidelines International Network Board of Trustees developed guidance on the disclosure of interests and management of COIs. Current approaches are relatively similar throughout the guideline development community, with an increasing recognition of the importance of disclosing and managing indirect COIs. Although there are differences in detail among the approaches, the similarities allow for the formulation of 9 core principles for managing COIs. In formulating these principles, the Guidelines International Network Board of Trustees recognizes that COIs cannot be totally avoided when panel members are being chosen for certain guidelines or in certain settings; thus, the important issue is the management of COIs in a fair, judicious, transparent manner.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Panel members disclosed all potential conflicts of interest. Conflicts were managed according to AGA and ACG policies, the National Academy of Medicine, and Guidelines International Network standards.”
In the citing paper
“CoIs in research activities are currently regulated by a set of norms, policies and guidelines for researchers participating in scientific investigations, clinical trials, peer-review and publication processes, and guideline development [282][283][284][285] .”
From Ethical challenges in contemporary psychiatry: an overview and an appraisal of possible strategies and research needs (2024) · cites this paper as [283]
Citations
Cites
Guidelines International Network: Toward International Standards for Clinical Practice Guidelines
Qaseem, A., Forland, F., Macbeth, F., Ollenschläger, G., Phillips, S., van der Wees, P., & for the Board of Trustees of the Guidelines International Network* (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-156-7-201204030-00009 · Cited by 902
Self-citationUnderstanding Financial Conflicts of Interest
Thompson, D. F. (1993) · New England Journal of Medicine · doi:10.1056/nejm199308193290812 · Cited by 854
Schünemann, H. J., Wiercioch, W., Etxeandia, I., Falavigna, M., Santesso, N., Mustafa, R., Ventresca, M., Brignardello-Petersen, R., Laisaar, K.-T., Kowalski, S., et al. (2014) · Canadian Medical Association Journal · doi:10.1503/cmaj.131237 · Cited by 686
Self-citationRelationships Between Authors of Clinical Practice Guidelines and the Pharmaceutical Industry
Choudhry, N. K. (2002) · JAMA · doi:10.1001/jama.287.5.612 · Cited by 646
A Social Science Perspective on Gifts to Physicians From Industry
Dana, J. (2003) · JAMA · doi:10.1001/jama.290.2.252 · Cited by 594 · cited 1×
“Although evidence suggests that any financial benefit can influence judgments about interventions in guidelines (23), direct relevance and larger amounts are considered more important than indirect relevance and lesser amounts.”
BackgroundThe Vexing Problem of Guidelines and Conflict of Interest: A Potential Solution
Guyatt, G., Akl, E. A., Hirsh, J., Kearon, C., Crowther, M., Gutterman, D., Lewis, S. Z., Nathanson, I., Jaeschke, R., & Schünemann, H. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-11-201006010-00254 · Cited by 325
Self-citationQaseem, A., Snow, V., Owens, D. K., Shekelle, P., & for the Clinical Guidelines Committee of the American College of Physicians (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-153-3-201008030-00010 · Cited by 233
Self-citationSchünemann, H. J., Osborne, M., Moss, J., Manthous, C., Wagner, G., Sicilian, L., Ohar, J., McDermott, S., Lucas, L., & Jaeschke, R. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200901-0126st · Cited by 115
Self-citationNorris, S. L., Burda, B. U., Holmer, H. K., Ogden, L. A., Fu, R. F., Bero, L. A., Schünemann, H. J., & Deyo, R. A. (2012) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2011.12.011 · Cited by 114
Self-citationAkl, E. A., El-Hachem, P., Abou‐Haidar, H., Neumann, I., Schünemann, H. J., & Guyatt, G. H. (2014) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2014.05.006 · Cited by 82
Self-citation
Cited by
Treatment of stage I–III periodontitis—The EFP S3 level clinical practice guideline
Sanz, M., Herrera, D., Kebschull, M., Chapple, I., Jepsen, S., Berglundh, T., Sculean, A., Tonetti, M. S., & Consultants, E. W. P. A. M. (2020) · Journal of Clinical Periodontology · doi:10.1111/jcpe.13290 · Cited by 1,934
“Management of conflict of interests (CoIs) was discussed in the working groups, following the principles provided by the Guidelines International Network (Schunemann et al., 2015).”
MethodInfluentialAmerican Society of Hematology 2019 guidelines for immune thrombocytopenia
Neunert, C., Terrell, D. R., Arnold, D. M., Buchanan, G., Cines, D. B., Cooper, N., Cuker, A., Despotovic, J. M., George, J. N., Grace, R. F., et al. (2019) · Blood Advances · doi:10.1182/bloodadvances.2019000966 · Cited by 1,406
“Conflicts of interest of all participants were managed through disclosure, panel composition, and recusal, according to recommendations of the Institute of Medicine 38 and the GIN.”
InfluentialAlonso-Coello, P., Schünemann, H. J., Moberg, J., Brignardello-Petersen, R., Akl, E. A., Davoli, M., Treweek, S., Mustafa, R. A., Rada, G., Rosenbaum, S., et al. (2016) · BMJ · doi:10.1136/bmj.i2016 · Cited by 1,317
Self-citationLyman, G. H., Carrier, M., Ay, C., Di Nisio, M., Hicks, L. K., Khorana, A. A., Leavitt, A. D., Lee, A. Y. Y., Macbeth, F., Morgan, R. L., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2020003442 · Cited by 893
“Conflicts of interest of all participants were managed according to ASH policies based on recommendations of the National Academy of Medicine(47) and GIN.(4) At the time of appointment, a majority of the guideline panel, including 1 of the clinical cochairs and the vice chair, had no conflicts of interest as defined a…”
BackgroundMethodInfluentialSelf-citationSchünemann, H. J., Cushman, M., Burnett, A. E., Kahn, S. R., Beyer-Westendorf, J., Spencer, F. A., Rezende, S. M., Zakai, N. A., Bauer, K. A., Dentali, F., et al. (2018) · Blood Advances · doi:10.1182/bloodadvances.2018022954 · Cited by 819
Self-citationCuker, A., Arepally, G. M., Chong, B. H., Cines, D. B., Greinacher, A., Gruel, Y., Linkins, L. A., Rodner, S. B., Selleng, S., Warkentin, T. E., et al. (2018) · Blood Advances · doi:10.1182/bloodadvances.2018024489 · Cited by 750
Anderson, D. R., Morgano, G. P., Bennett, C., Dentali, F., Francis, C. W., Garcia, D. A., Kahn, S. R., Rahman, M., Rajasekhar, A., Rogers, F. B., et al. (2019) · Blood Advances · doi:10.1182/bloodadvances.2019000975 · Cited by 626
“The guideline panel developed and graded the recommendations and assessed the certainty in the supporting evidence following the GRADE approach.5,6,12-16 The overall guideline-development process, including funding of the work, panel formation, management of conflicts of interest, internal and external review, and org…”
BackgroundMethodInfluentialSelf-citationBates, S. M., Rajasekhar, A., Middeldorp, S., McLintock, C., Rodger, M. A., James, A. H., Vazquez, S. R., Greer, I. A., Riva, J. J., Bhatt, M., et al. (2018) · Blood Advances · doi:10.1182/bloodadvances.2018024802 · Cited by 625
ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease
James, P. D., Connell, N. T., Ameer, B., Di Paola, J., Eikenboom, J., Giraud, N., Haberichter, S., Jacobs-Pratt, V., Konkle, B., McLintock, C., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2020003265 · Cited by 586
Witt, D. M., Nieuwlaat, R., Clark, N. P., Ansell, J., Holbrook, A., Skov, J., Shehab, N., Mock, J., Myers, T., Dentali, F., et al. (2018) · Blood Advances · doi:10.1182/bloodadvances.2018024893 · Cited by 511
“During all deliberations, panel members with a current, direct financial interest in a commercial entity with any product that could be affected by the guidelines were recused from making judgments about relevant recommendations.(5,18-20) The Evidence-to-Decision (EtD) framework for each recommendation describes which…”
BackgroundMethodInfluentialAmerican Society of Hematology 2020 guidelines for sickle cell disease: transfusion support
Chou, S. T., Alsawas, M., Fasano, R. M., Field, J. J., Hendrickson, J. E., Howard, J., Kameka, M., Kwiatkowski, J. L., Pirenne, F., Shi, P. A., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2019001143 · Cited by 497
“RECOMMENDATION 10b.”
InfluentialPrevention and treatment of peri‐implant diseases—The EFP S3 level clinical practice guideline
Herrera, D., Berglundh, T., Schwarz, F., Chapple, I., Jepsen, S., Sculean, A., Kebschull, M., Papapanou, P. N., Tonetti, M. S., Sanz, M., et al. (2023) · Journal of Clinical Periodontology · doi:10.1111/jcpe.13823 · Cited by 505
“Management of CoIs was discussed in the WGs and the plenary sessions, following the principles provided by the Guidelines International Network (Schunemann et al., 2015).”
MethodMonagle, P., Cuello, C. A., Augustine, C., Bonduel, M., Brandão, L. R., Capman, T., Chan, A. K. C., Hanson, S., Male, C., Meerpohl, J., et al. (2018) · Blood Advances · doi:10.1182/bloodadvances.2018024786 · Cited by 461
“During all deliberations, panel members with a current and direct financial interest in a commercial entity with any product that could be affected by the guidelines were recused from making judgments about relevant recommendations.(4,18-20) The Evidence-to-Decision (EtD) framework for each recommendation describes wh…”
BackgroundMethodInfluentialBrandow, A. M., Carroll, C. P., Creary, S., Edwards-Elliott, R., Glassberg, J., Hurley, R. W., Kutlar, A., Seisa, M., Stinson, J., Strouse, J. J., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2020001851 · Cited by 456
“Conflicts of interest of all participants were managed through disclosure, panel composition, and recusal, according to ASH policies based on recommendations of the Institute of Medicine20 and the GIN.9 Participants disclosed all financial and nonfinancial interests relevant to the guideline topic.”
MethodInfluentialKottner, J., Cuddigan, J., Carville, K., Balzer, K., Berlowitz, D., Law, S., Litchford, M., Mitchell, P., Moore, Z., Pittman, J., et al. (2019) · Journal of Tissue Viability · doi:10.1016/j.jtv.2019.01.001 · Cited by 438
“Potential COI are declared and managed based on an adapted version of the Guidelines International Network Principles [24]: (1) Every GGG and SWG member must declare any potential COI according to the Disclosure Form (Supplementary material) on an annual basis during the guideline development.”
BackgroundMethodInfluentialDeBaun, M. R., Jordan, L. C., King, A. A., Schatz, J., Vichinsky, E., Fox, C. K., McKinstry, R. C., Telfer, P., Kraut, M. A., Daraz, L., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2019001142 · Cited by 434
“Recusal was also used to manage conflicts of interest.(14,34-36) During deliberations about recommendations, any panel member with a current, direct financial interest in a commercial entity that marketed any product that could be affected by a specific recommendation participated in discussions about the evidence and…”
MethodInfluentialLim, W., Le Gal, G., Bates, S. M., Righini, M., Haramati, L. B., Lang, E., Kline, J. A., Chasteen, S., Snyder, M., Patel, P., et al. (2018) · Blood Advances · doi:10.1182/bloodadvances.2018024828 · Cited by 418
“The guideline panel developed and graded the recommendations and assessed the certainty in the supporting evidence following the GRADE approach.5,6 The overall guideline development process, including funding of the work, panel formation, management of conflicts of interest, internal and external review, and organizat…”
BackgroundMethodInfluentialSelf-citationTreatment of stage IV periodontitis: The EFP S3 level clinical practice guideline
Herrera, D., Sanz, M., Kebschull, M., Jepsen, S., Sculean, A., Berglundh, T., Papapanou, P. N., Chapple, I., Tonetti, M. S., & Consultant, E. W. P. A. M. (2022) · Journal of Clinical Periodontology · doi:10.1111/jcpe.13639 · Cited by 408
Management of opioid use disorders: a national clinical practice guideline
Bruneau, J., Ahamad, K., Goyer, M.-È., Poulin, G., Selby, P., Fischer, B., Wild, T. C., & Wood, E. (2018) · Canadian Medical Association Journal · doi:10.1503/cmaj.170958 · Cited by 412
Cuker, A., Tseng, E. K., Nieuwlaat, R., Angchaisuksiri, P., Blair, C., Dane, K., Davila, J., DeSancho, M. T., Diuguid, D., Griffin, D. O., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2020003763 · Cited by 408
“…recent systematic review search dates (19 July 2020 for the baseline risk review and 19 August 2020 for review of the anticoagulation-intensity effect) and fulfilled the inclusion criteria for the individual questions (see supplemental Files 6 and 7 for the search strategies per targeted database).”
Self-citationASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease
Connell, N. T., Flood, V. H., Brignardello-Petersen, R., Abdul-Kadir, R., Arapshian, A., Couper, S., Grow, J. M., Kouides, P., Laffan, M., Lavin, M., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2020003264 · Cited by 402
“The guideline panel developed and graded the recommendations and assessed the certainty in the supporting evidence following the GRADE approach.4-10 The overall guideline development process, including funding of the work, panel formation, management of conflicts of interest, internal and external reviews, and organiz…”
MethodChu, D. K., Schneider, L., Asiniwasis, R. N., Boguniewicz, M., De Benedetto, A., Ellison, K., Frazier, W. T., Greenhawt, M., Huynh, J., Kim, E., et al. (2024) · Annals of Allergy, Asthma & Immunology · doi:10.1016/j.anai.2023.11.009 · Cited by 380
The GRADE Evidence to Decision (EtD) framework for health system and public health decisions
for the GRADE Working Group, Moberg, J., Oxman, A. D., Rosenbaum, S., Schünemann, H. J., Guyatt, G., Flottorp, S., Glenton, C., Lewin, S., Morelli, A., et al. (2018) · Health Research Policy and Systems · doi:10.1186/s12961-018-0320-2 · Cited by 376
“Guideline developers and organisations responsible for healthcare decisions should consider conflicts of interest when a panel is established [29].”
BackgroundSelf-citationDuncan, H. F., Kirkevang, L., Peters, O. A., El‐Karim, I., Krastl, G., Del Fabbro, M., Chong, B. S., Galler, K. M., Segura‐Egea, J. J., Kebschull, M., et al. (2023) · International Endodontic Journal · doi:10.1111/iej.13974 · Cited by 304
Brunt, L. M., Deziel, D. J., Telem, D. A., Strasberg, S. M., Aggarwal, R., Asbun, H., Bonjer, J., McDonald, M., Alseidi, A., Ujiki, M., et al. (2020) · Annals of Surgery · doi:10.1097/sla.0000000000003791 · Cited by 268
Middeldorp, S., Nieuwlaat, R., Baumann Kreuziger, L., Coppens, M., Houghton, D., James, A. H., Lang, E., Moll, S., Myers, T., Bhatt, M., et al. (2023) · Blood Advances · doi:10.1182/bloodadvances.2023010177 · Cited by 279
Self-citationvan Mastrigt, G. A. P. G., Hiligsmann, M., Arts, J. J. C., Broos, P. H., Kleijnen, J., Evers, S. M. A. A., & Majoie, M. H. J. M. (2016) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2016.1246960 · Cited by 219
“GIN has published a recent paper on the principles of managing conflicts of interest in guideline development [30].”
BackgroundSingh, S., Loftus, E. V., Limketkai, B. N., Haydek, J. P., Agrawal, M., Scott, F. I., & Ananthakrishnan, A. N. (2024) · Gastroenterology · doi:10.1053/j.gastro.2024.10.001 · Cited by 204
Morin, S. N., Feldman, S., Funnell, L., Giangregorio, L., Kim, S., McDonald-Blumer, H., Santesso, N., Ridout, R., Ward, W., Ashe, M. C., et al. (2023) · Canadian Medical Association Journal · doi:10.1503/cmaj.221647 · Cited by 210
Sekeres, M. A., Guyatt, G., Abel, G., Alibhai, S., Altman, J. K., Buckstein, R., Choe, H., Desai, P., Erba, H., Hourigan, C. S., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2020001920 · Cited by 188
“Conflicts of interest of all participants were managed through disclosure, panel composition, and recusal, which were recommendations of the Institute of Medicine andGIN.(1-4) Participants disclosed all financial and nonfinancial interests relevant to the guideline topic.”
BackgroundMethodInfluentialSCAI Guidelines for the Management of Patent Foramen Ovale
Kavinsky, C. J., Szerlip, M., Goldsweig, A. M., Amin, Z., Boudoulas, K. D., Carroll, J. D., Coylewright, M., Elmariah, S., MacDonald, L. A., Shah, A. P., et al. (2022) · Journal of the Society for Cardiovascular Angiography & Interventions · doi:10.1016/j.jscai.2022.100039 · Cited by 181
Bégin, P., Chan, E. S., Kim, H., Wagner, M., Cellier, M. S., Favron-Godbout, C., Abrams, E. M., Ben-Shoshan, M., Cameron, S. B., Carr, S., et al. (2020) · Allergy, Asthma & Clinical Immunology · doi:10.1186/s13223-020-0413-7 · Cited by 182
Liem, R. I., Lanzkron, S., D. Coates, T., DeCastro, L., Desai, A. A., Ataga, K. I., Cohen, R. T., Haynes, J., Osunkwo, I., Lebensburger, J. D., et al. (2019) · Blood Advances · doi:10.1182/bloodadvances.2019000916 · Cited by 182
“The panel identified the following additional types of research that are needed: (1) prospective studies evaluating the utility of adding NT-BNP and 6MWD to findings on ECHO, including peak TRJV, to improve diagnostic yield for patients with SCD undergoing evaluation for PH; (2) prospective studies to better character…”
BackgroundMethodInfluentialChang, L., Chey, W. D., Imdad, A., Almario, C. V., Bharucha, A. E., Diem, S., Greer, K. B., Hanson, B., Harris, L. A., Ko, C., et al. (2023) · Gastroenterology · doi:10.1053/j.gastro.2023.03.214 · Cited by 185
Brunt, L. M., Deziel, D. J., Telem, D. A., Strasberg, S. M., Aggarwal, R., Asbun, H. J., Bonjer, H. J., McDonald, M. P., Alseidi, A. A., Ujiki, M., et al. (2020) · Surgical Endoscopy · doi:10.1007/s00464-020-07568-7 · Cited by 204
American Society of Hematology 2021 guidelines for sickle cell disease: stem cell transplantation
Kanter, J., Liem, R. I., Bernaudin, F., Bolaños‐Meade, J., Fitzhugh, C. D., Hankins, J. S., Murad, M. H., Panepinto, J. A., Rondelli, D., Shenoy, S. S., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2021004394c · Cited by 152
Morgan, R. L., Flórez, I. D., Falavigna, M., Kowalski, S. C., Akl, E. A., Thayer, K. A., Rooney, A. A., & Schünemann, H. J. (2018) · Health Research Policy and Systems · doi:10.1186/s12961-018-0330-0 · Cited by 137
Self-citationReporting of declarations and conflicts of interest in WHO guidelines can be further improved
Wang, X., Chen, Y., Yao, L., Zhou, Q. X., Wu, Q., Estill, J. A. M., Wang, Q., Yang, K., & Norris, S. L. (2017) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2017.12.021 · Cited by 116
The ecosystem of health decision making: from fragmentation to synergy
Schünemann, H. J., Reinap, M., Piggott, T., Laidmäe, E., Köhler, K., Põld, M., Ens, B., Irs, A., Akl, E. A., Cuello‐García, C. A., et al. (2022) · The Lancet Public Health · doi:10.1016/s2468-2667(22)00057-3 · Cited by 140
Self-citationDistinguishing opinion from evidence in guidelines
Schünemann, H. J., Zhang, Y., & Oxman, A. D. (2019) · BMJ · doi:10.1136/bmj.l4606 · Cited by 106
Self-citationScandinavian SSAI clinical practice guideline on pre‐hospital airway management
Rehn, M., Hyldmo, P. K., Magnússon, V., Kurola, J. O., Kongstad, P., Rognås, L. K., Juvet, L. K., & Sandberg, M. (2016) · Acta Anaesthesiologica Scandinavica · doi:10.1111/aas.12746 · Cited by 123
Injectable opioid agonist treatment for opioid use disorder: a national clinical guideline
Fairbairn, N. S., Ross, J. W. G., Trew, M., Meador, K., Turnbull, J., Macdonald, S., Oviedo‐Joekes, E., Foll, B. L., Goyer, M.-È., Perreault, M., et al. (2019) · Canadian Medical Association Journal · doi:10.1503/cmaj.190344 · Cited by 101
Rubenstein, J. H., Sawas, T., Wani, S. B., Eluri, S., Singh, S., Chandar, A. K., Perumpail, R. B., Inadomi, J. M., Thrift, A. P., Piscoya, A., et al. (2024) · Gastroenterology · doi:10.1053/j.gastro.2024.03.019 · Cited by 100
Qaseem, A., Wilt, T. J., Forciea, M. A., Kansagara, D., Crandall, C. J., Fitterman, N., Hicks, L. A., Horwitch, C. A., Lin, J. S., Maroto, M., et al. (2019) · Annals of Internal Medicine · doi:10.7326/m18-3279 · Cited by 90
Self-citationWest, N. X., Chapple, I., Claydon, N., D’Aiuto, F., Donos, N., Ide, M., Needleman, I. G., & Kebschull, M. (2021) · Journal of Dentistry · doi:10.1016/j.jdent.2020.103562 · Cited by 97
Monagle, P., Azzam, M., Bercovitz, R. S., Betensky, M., Bhat, R. V., Biss, T. T., Branchford, B. R., Brandão, L. R., Chan, A. K. C., Faustino, E. V. S., et al. (2025) · Blood Advances · doi:10.1182/bloodadvances.2024015328 · Cited by 106
Cuker, A., Tseng, E. K., Nieuwlaat, R., Angchaisuksiri, P., Blair, C., Dane, K., Davila, J., DeSancho, M. T., Diuguid, D., Griffin, D. O., et al. (2022) · Blood Advances · doi:10.1182/bloodadvances.2021005945 · Cited by 78
Self-citationMagni, P., Bier, D. M., Pecorelli, S., Agostoni, C. V., Astrup, A. V., Brighenti, F., Cook, R., Folco, E., Fontana, L., Gibson, R. A., et al. (2017) · Advances in Nutrition · doi:10.3945/an.116.014738 · Cited by 97
Self-citationGalderisi, S., Appelbaum, P. S., Gill, N., Gooding, P., Herrman, H., Melillo, A., Myrick, K., Pathare, S., Savage, M., Szmukler, G., et al. (2024) · World Psychiatry · doi:10.1002/wps.21230 · Cited by 76
Canadian Guideline for the Clinical Management of High-Risk Drinking and Alcohol Use Disorder
Wood, E., Bright, J., Hsu, K., Goel, N., Ross, J. W. G., Hanson, A., Teed, R., Poulin, G., Denning, B., Corace, K., et al. (2023) · Canadian Medical Association Journal · doi:10.1503/cmaj.230715 · Cited by 74
Pharmacotherapy for obesity management in adults: 2025 clinical practice guideline update
Pedersen, S. D., Manjoo, P., Dash, S., Jain, A., Pearce, N., & Poddar, M. (2025) · Canadian Medical Association Journal · doi:10.1503/cmaj.250502 · Cited by 78
“We adhered to the Appraisal of Guidelines for Research and Evaluation (AGREE II) framework 76 and Guidelines International Network (GIN) principles 77 in developing the guideline.”
Key issues for stakeholder engagement in the development of health and healthcare guidelines
Petkovic, J., Magwood, O., Lytvyn, L., Khabsa, J., Concannon, T. W., Welch, V. A., Todhunter‐Brown, A., Palm, M. E., Akl, E. A., Mbuagbaw, L. C. E., et al. (2023) · Research Involvement and Engagement · doi:10.1186/s40900-023-00433-6 · Cited by 96
“While guidance for conflict of interest management in guideline development is available [21, 22], guidance that specifically addresses the management of conflict of interest in the context of multi-stakeholder engagement is lacking.”
BackgroundSelf-citationEuropean Resuscitation Council Guidelines 2025 Executive Summary
Greif, R., Lauridsen, K. G., Djärv, T., Ek, J. E., Monnelly, V., Monsieurs, K. G., Nikolaou, N. I., Olasveengen, T. M., Semeraro, F. F., Spartinou, A., et al. (2025) · Resuscitation · doi:10.1016/j.resuscitation.2025.110770 · Cited by 160
Cuker, A. C., Tseng, E. K., Nieuwlaat, R., Angchaisuksiri, P., Blair, C., Dane, K. E., DeSancho, M. T., Diuguid, D. L., Griffin, D. O., Kahn, S. R., et al. (2022) · Blood Advances · doi:10.1182/bloodadvances.2022007561 · Cited by 75
Self-citationGrundy, Q., Mayes, C., Holloway, K., Mazzarello, S., Thombs, B., & Bero, L. (2019) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2019.12.014 · Cited by 35
ONS Guidelines™ for Cancer Treatment–Related Lymphedema
Armer, J. M., Ostby, P. L., Ginex, P., Beck, M., Deng, J. F., Fu, M. R., Lasinski, B. B., Lockwood, S., Poage, E., White, J. P., et al. (2020) · Oncology nursing forum · doi:10.1188/20.onf.518-538 · Cited by 78
“Financial and intellectual disclosures of interest of all participants were collected and managed according to ONS policies and the recommendations of the NASEM and the Guideline International Network (Institute of Medicine, 2011; Schünemann et al., 2015).”
MethodNHF‐McMaster Guideline on Care Models for Haemophilia Management
Pai, M., Key, N. S., Skinner, M. W., Curtis, R., Feinstein, M., Kessler, C. M., Lane, S. J., Makris, M., Riker, E., Santesso, N. A., et al. (2016) · Haemophilia · doi:10.1111/hae.13008 · Cited by 68
Self-citationCuker, A. C., Tseng, E. K., Nieuwlaat, R., Angchaisuksiri, P., Blair, C., Dane, K. E., Davila, J. G., DeSancho, M. T., Diuguid, D. L., Griffin, D. O., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2021005493 · Cited by 70
Self-citationONS Guidelines™ for Cancer Treatment–Related Radiodermatitis
Gosselin, T., Ginex, P., Backler, C., Bruce, S. D., Hutton, A., Marquez, C., McGee, L. A., Shaftic, A. M., Suarez, L., Moriarty, K., et al. (2020) · Oncology nursing forum · doi:10.1188/20.onf.654-670 · Cited by 65
“Financial and intellectual disclosures of interest of all participants were collected and managed according to ONS policies and the recommendations of NASEM and GIN (Institute of Medicine, 2011; Schünemann et al., 2015).”
MethodBlake, P., Durão, S., Naude, C. E., & Bero, L. A. (2018) · Nutrition Reviews · doi:10.1093/nutrit/nux074 · Cited by 76
Hakoum, M. B., Anouti, S., Al-Gibbawi, M., Abou-Jaoude, E. A., Hasbani, D. J., Lopes, L. C., Agarwal, A., Guyatt, G., & Akl, E. A. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-011997 · Cited by 59
Schünemann, H. J., Donata, L., Dimitrova, N., Alonso‐Coello, P., Gräwingholt, A., Quinn, C., Follmann, M., Mansel, R. E., Sardanelli, F., Rossi, P. G., et al. (2019) · Annals of Internal Medicine · doi:10.7326/m18-3445 · Cited by 61
Self-citationKey populations for early COVID-19 immunization: preliminary guidance for policy
Ismail, S. J., Zhao, L., Tunis, M. C., Deeks, S. L., & Quach, C. (2020) · Canadian Medical Association Journal · doi:10.1503/cmaj.202353 · Cited by 57
Managing obesity in children: a clinical practice guideline
Ball, G. D. C., Merdad, R., Birken, C. S., Cohen, T. R., Goodman, B., Hadjiyannakis, S., Hamilton, J., Henderson, M., Lammey, J., Morrison, K. M., et al. (2025) · Canadian Medical Association Journal · doi:10.1503/cmaj.241456 · Cited by 56
“…from the National Academy of Medicine (formerly the Institute of Medicine), 52 the GRADE working group, 53–55 Guidelines International Network, 56 and the Guidance for Reporting Involvement of Patients and the Public (short-form) reporting checklist 57 (Appendix 2, available at www.cmaj.ca/…”
InfluentialManaging conflicts of interest in the development of health guidelines
Traversy, G., Barnieh, L., Akl, E. A., Allan, G. M., Brouwers, M. C., Ganache, I., Grundy, Q., Guyatt, G. H., Kelsall, D., Leng, G. C., et al. (2021) · Canadian Medical Association Journal · doi:10.1503/cmaj.200651 · Cited by 61
Self-citationLotfi, T., Stevens, A., Akl, E. A., Falavigna, M., Kredo, T., Mathew, J. L., & Schünemann, H. J. (2021) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2021.03.034 · Cited by 60
Self-citationMapping conflict of interests: scoping review
Chimonas, S., Mamoor, M., Zimbalist, S. A., Barrow, B., Bach, P. B., & Korenstein, D. (2021) · BMJ · doi:10.1136/bmj-2021-066576 · Cited by 54
Ye, Z., Rochwerg, B. N., Wang, Y., Adhikari, N. K. J., Murthy, S., Lamontagne, F., Fowler, R., Qiu, H., Li, W., Sang, L., et al. (2020) · Canadian Medical Association Journal · doi:10.1503/cmaj.200648 · Cited by 55
Management of opioid use disorder: 2024 update to the national clinical practice guideline
Yakovenko, I., Mukaneza, Y., Germé, K., Belliveau, J., Fraleigh, R., Bach, P., Poulin, G., Selby, P. L., Goyer, M.-È., Brothers, T. D., et al. (2024) · Canadian Medical Association Journal · doi:10.1503/cmaj.241173 · Cited by 74
“52 All the guideline development committee members and external reviewers were required to complete a standardized form 52 at different time points: at the beginning of the guideline development process and before the external review process.”
The reporting checklist for public versions of guidelines: RIGHT-PVG
The RIGHT working group, Wang, X., Chen, Y., Akl, E. A., Tokalić, R., Marušić, A., Qaseem, A., Falck-Ytter, Y. T., Lee, M. S., Siedler, M. R., et al. (2021) · Implementation Science · doi:10.1186/s13012-020-01066-z · Cited by 52
“Additionally, a trustworthy guideline should report conflicts of interest transparently [35, 36], while the PVG should report the conflicts of interest in a format that patients and the public can easily understand and assess their potential impact.”
BackgroundSelf-citationBrożek, J., Firmino, R. T., Bognanni, A., Arasi, S., Ansotegui, I. J., Assa’ad, A., Bahna, S. L., Canani, R. B., Bózzola, M., Chu, D. K., et al. (2022) · World Allergy Organization Journal · doi:10.1016/j.waojou.2022.100646 · Cited by 58
“The guideline panel developed and graded the recommendations and assessed the certainty in the supporting evidence following the GRADE approach.4,5 The overall guideline-development process, including funding of the work, panel formation, management of conflicts of interest, internal and external review, and organizat…”
MethodInfluentialSelf-citationBognanni, A., Fiocchi, A. G., Arasi, S., Chu, D. K., Ansotegui, I. J., Assa’ad, A., Bahna, S. L., Canani, R. B., Bózzola, M., Dahdah, L., et al. (2024) · World Allergy Organization Journal · doi:10.1016/j.waojou.2024.100888 · Cited by 70
Self-citationLang, E., Colquhoun, H. L., LeBlanc, J. C., Riva, J. J., Moore, A. E., Traversy, G., Wilson, B. J., & Grad, R. M. (2022) · Canadian Medical Association Journal · doi:10.1503/cmaj.220290 · Cited by 59
Jain, R., Stone, J. A., Agarwal, G., Andrade, J. G., Bacon, S., BAJAJ, H. S., Baker, B., Cheng, G., Dannenbaum, D. A., Gelfer, M., et al. (2022) · Canadian Medical Association Journal · doi:10.1503/cmaj.220138 · Cited by 56
Diagnosing acute aortic syndrome: a Canadian clinical practice guideline
Ohle, R., Yan, J. W., Yadav, K., Cournoyer, A., Savage, D. W., Jetty, P., Atoui, R., Bittira, B., Wilson, B., Gupta, A. K., et al. (2020) · Canadian Medical Association Journal · doi:10.1503/cmaj.200021 · Cited by 51
Cuker, A. C., Tseng, E. K., Schünemann, H. J., Angchaisuksiri, P., Blair, C., Dane, K. E., DeSancho, M. T., Diuguid, D. L., Griffin, D. O., Kahn, S. R., et al. (2022) · Blood Advances · doi:10.1182/bloodadvances.2022007940 · Cited by 48
Self-citation2025 SCAI/HRS clinical practice guidelines on transcatheter left atrial appendage occlusion
Goldsweig, A. M., Glikson, M., Joza, J. E., Kavinsky, C. J., Khalique, O. K., Lakkireddy, D., Mackensen, G. B., Naccarelli, G. V., Nair, D. G., Saw, J., et al. (2025) · Heart Rhythm · doi:10.1016/j.hrthm.2025.05.048 · Cited by 68
Tissot‐Dupont, H., Casalta, J., Gouriet, F., Hubert, S., Salaün, E., Habib, G., Fernandez‐Gerlinger, M., Mainardi, J., Tattevin, P., Revest, M., et al. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.03.007 · Cited by 53
AGA Clinical Practice Guideline on Surveillance of Barrett’s Esophagus
Wani, S., Zhou, M. J., Sawas, T., Rubenstein, J. H., Eluri, S., Leiman, D. A., Sultan, S., Singh, S., Inadomi, J. M., Thrift, A. P., et al. (2025) · Gastroenterology · doi:10.1053/j.gastro.2025.09.012 · Cited by 49
Conflicts of interest disclosure forms and management in critical care clinical practice guidelines
Alhazzani, W., Lewis, K., Jaeschke, R., Rochwerg, B., Møller, M. H., Evans, L., Wilson, K. C., Patel, S., Coopersmith, C. M., Cecconi, M., et al. (2018) · Intensive Care Medicine · doi:10.1007/s00134-018-5367-6 · Cited by 42
Chang, L., Chey, W. D., Imdad, A., Almario, C. V., Bharucha, A. E., Diem, S. J., Greer, K. B., Hanson, B., Harris, L. A., Ko, C. W., et al. (2023) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000002227 · Cited by 56
Jenssen, C., Gilja, O. H., Serra, A. L., Piscaglia, F., Dietrich, C. F., Rudd, L., & Sidhu, P. S. (2018) · Ultrasound International Open · doi:10.1055/a-0770-3965 · Cited by 46
Heyen, N. B., & Salloch, S. (2021) · BMC Medical Ethics · doi:10.1186/s12910-021-00679-3 · Cited by 48
Preventive care recommendations to promote health equity
Persaud, N., Sabir, A., Woods, H., Sayani, A., Agarwal, A., Chowdhury, M., de Leon-Demare, K., Ibezi, S., Jan, S. H., Katz, A., et al. (2023) · Canadian Medical Association Journal · doi:10.1503/cmaj.230237 · Cited by 56
Policies on Conflicts of Interest in Health Care Guideline Development: A Cross-Sectional Analysis
Morciano, C., Basevi, V., Faralli, C., Boon, M. H., Tonon, S., & Taruscio, D. (2016) · PLoS ONE · doi:10.1371/journal.pone.0166485 · Cited by 40
on behalf of the Italian National Institute of Health guideline working group on Autism Spectrum Disorder, Morgano, G. P., Fulceri, F., Nardocci, F., Barbui, C., Ostuzzi, G., Papola, D., Fatta, L. M., Fauci, A. J., Coclite, D., et al. (2020) · Health and Quality of Life Outcomes · doi:10.1186/s12955-020-01320-4 · Cited by 36
Self-citationWiercioch, W., Nieuwlaat, R., Akl, E. A., Kunkle, R., Alexander, K. E., Cuker, A. C., Rajasekhar, A., Alonso‐Coello, P., Anderson, D. R., Bates, S. M., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2020001768 · Cited by 43
Self-citationIftikhar, R., DeFilipp, Z. M., Dezern, A. E., Pulsipher, M. A., Bejanyan, N., Burroughs, L. M., Kharfan‐Dabaja, M. A., Arai, S., Kassim, A. A., Nakamura, R., et al. (2024) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2024.09.017 · Cited by 35
Clinical practice guidelines and the overuse of health care services: need for reform
Jatoi, I., & Sah, S. (2019) · Canadian Medical Association Journal · doi:10.1503/cmaj.181496 · Cited by 39
Elder, K., Turner, K. A., Cosgrove, L., Lexchin, J., Shnier, A., Moore, A. E., Straus, S. E., & Thombs, B. D. (2020) · Canadian Medical Association Journal · doi:10.1503/cmaj.191737 · Cited by 37
Conflicts of interest and Scientific Societies
For the Bioethics and Palliative Care Study Group of the Italian Neurological Society, Gasparini, M., Tarquini, D., Pucci, E., Alberti, F., D’Alessandro, R., Marogna, M., Veronese, S., & Porteri, C. (2020) · Neurological Sciences · doi:10.1007/s10072-020-04330-8 · Cited by 33
“A “monitoring committee” to settle disputes and advise the GDG (Guideline Development Groups) coordinator is also recommended in the principles developed by theBoard of Trustees of the International NetworkGuidelines (GINBoard of Trustees), to which reference can be made for the disclosure and management of conflicts…”
MethodWentzensen, N., García, F., Clarke, M. A., Massad, L. S., Cheung, L. C., Egemen, D., Guido, R. S., Huh, W. K., Saslow, D., Smith, R. A., et al. (2024) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0000000000000804 · Cited by 37
Torgerson, T., Wayant, C., Cosgrove, L., Akl, E. A., Checketts, J. X., Dal‐Ré, R., Gill, J., Grover, S. C., Khan, N. A., Khan, R., et al. (2020) · BMJ Evidence-Based Medicine · doi:10.1136/bmjebm-2020-111503 · Cited by 41
Hakoum, M. B., Jouni, N., Abou-Jaoude, E. A., Hasbani, D. J., Abou-Jaoude, E. A., Lopes, L. C., Khaldieh, M., Hammoud, M. Z., Al‐Gibbawi, M., Anouti, S., et al. (2017) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2017.04.002 · Cited by 34
Murayama, A., Yamada, K., Yoshida, M., Kaneda, Y., Saito, H., Sawano, T., Shrestha, S., Shrestha, R., Tanimoto, T. E., & Ozaki, A. (2022) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.14661121 · Cited by 30
Conflict of Interest in Seminal Hepatitis C Virus and Cholesterol Management Guidelines
Jefferson, A. A., & Pearson, S. D. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.8439 · Cited by 31
The Need to Systematically Evaluate Clinical Practice Guidelines
Shaughnessy, A. F., Cosgrove, L., & Lexchin, J. (2016) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2016.06.160115 · Cited by 30
ONS Guidelines™ for Cancer Treatment–Related Skin Toxicity
Williams, L. A., Ginex, P., Ebanks, G., Ganstwig, K., Ciccolini, K. T., Kwong, B. Y., Robison, J., Shelton, G., Strelo, J. L., Wiley, K., et al. (2020) · Oncology nursing forum · doi:10.1188/20.onf.539-556 · Cited by 31
“Financial and intellectual disclosures of interest of all participants were collected and managed according to ONS policies and the recommendations of NASEM and GIN (Graham et al., 2011; Schünemann et al., 2015).”
MethodGuidelines and Safety Practices for Improving Patient Safety
Ricciardi, W., & Cascini, F. (2020) · Springer eBooks · doi:10.1007/978-3-030-59403-9_1 · Cited by 43
Recommendations on screening for primary prevention of fragility fractures
Thériault, G., Limburg, H., Klarenbach, S. W., Reynolds, D. L., Riva, J. J., Thombs, B. D., Tessier, L. A., Grad, R. M., & Wilson, B. J. (2023) · Canadian Medical Association Journal · doi:10.1503/cmaj.221219 · Cited by 37
“76,77 The over-sight committee for evaluating and adjudicating competing interests included the task force chair (R.G., B.J.W.) during completion of this guideline and vice-chair (S.K.) and the director of PHAC’s Global Health and Guidelines Division.”
Metadata
- Authors
- Schünemann, H. J., Al-Ansary, L. A., Forland, F., Kersten, S., Komulainen, J., Kopp, I. B., Macbeth, F., Phillips, S. M., Robbins, C., van der Wees, P., Qaseem, A., & for the Board of Trustees of the Guidelines International Network*
- Affiliations
- Norwegian Institute of Public Health (NO)
- From McMaster University, Hamilton, Ontario, Canada; King Saud University, Riyadh, Saudi Arabia; Norwegian Institute of Public Health, Oslo, Norway; Integraal Kankercentrum Nederland, Utrecht, the Netherlands; Finnish Medical Society Duodecim, Helsinki, Finland; Association of the Scientific Medical Societies in Germany–Institute for Medical Knowledge Management, Marburg, Germany; Wales Cancer Trials Unit, Cardiff, United Kingdom; Therapeutic Guidelines, West Melbourne, Australia;
- ORCID
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2015-10-06
- Volume
- 163
- Issue
- 7
- Pages
- 548-553
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2117692444
- Cited by
- 337
- References
- 21
- Citations by year
- 2026: 23 · 2025: 50 · 2024: 30 · 2023: 41 · 2022: 42 · 2021: 31 · 2020: 50 · 2019: 16 · 2018: 22 · 2017: 15 · 2016: 15 · 2015: 2
- FWCI
- 20.96
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Topics
- Health Sciences › Nursing › Issues, ethics and legal aspects › Pharmaceutical industry and healthcare
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Clinical practice guidelines implementation
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Global Public Health Policies and Epidemiology
- Keywords
- conflicts of interest, conflict of interest disclosure, guideline development, financial conflicts of interest, transparency
- MeSH terms
- Humans, Conflict of Interest, Guidelines as Topic, Disclosure, Biomedical Research
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.